Literature DB >> 15520403

Clinical genetic counselling for familial cancers requires reliable data on familial cancer risks and general action plans.

K Hemminki1, C Eng.   

Abstract

Familial cancer clustering, without obvious heritability, poses a major challenge for current cancer risk assessment and management. Reliable determination of familial risks for cancer is important for clinical genetic counselling, but medically verified data on familial risks for many malignancies have been limited. However, the nationwide Swedish Family-Cancer Database allows a reliable characterisation of familial risk for all major neoplasms. Even though alert genetic counsellors and certainly clinical cancer geneticists will consider familial cancer clustering in their purview, the standard medical referral systems, which have already been shown to be poor in capturing and referring families at high risk for heritable cancers, are unlikely to ascertain familial aggregations of other cancers that are not known to belong to an inherited cancer syndrome. The data will be helpful in implementing evidence based guidelines for helping the general medical system to ascertain and refer even familial cancer clusters to cancer genetics professionals.

Entities:  

Mesh:

Year:  2004        PMID: 15520403      PMCID: PMC1735611          DOI: 10.1136/jmg.2004.022731

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  53 in total

1.  Polygenic susceptibility to breast cancer and implications for prevention.

Authors:  Paul D P Pharoah; Antonis Antoniou; Martin Bobrow; Ron L Zimmern; Douglas F Easton; Bruce A J Ponder
Journal:  Nat Genet       Date:  2002-03-04       Impact factor: 38.330

Review 2.  Hereditary colorectal cancer.

Authors:  Henry T Lynch; Albert de la Chapelle
Journal:  N Engl J Med       Date:  2003-03-06       Impact factor: 91.245

3.  Use of fear-appeal techniques in the design of tailored cancer risk communication messages: implications for healthcare providers.

Authors:  Kevin M Sweet; Sharla K Willis; Sato Ashida; Judith A Westman
Journal:  J Clin Oncol       Date:  2003-09-01       Impact factor: 44.544

4.  American Cancer Society guidelines for the early detection of cancer.

Authors:  Robert A Smith; Vilma Cokkinides; Andrew C von Eschenbach; Bernard Levin; Carmel Cohen; Carolyn D Runowicz; Stephen Sener; Debbie Saslow; Harmon J Eyre
Journal:  CA Cancer J Clin       Date:  2002 Jan-Feb       Impact factor: 508.702

5.  Familial and second gastric carcinomas: a nationwide epidemiologic study from Sweden.

Authors:  Kari Hemminki; Yongwen Jiang
Journal:  Cancer       Date:  2002-02-15       Impact factor: 6.860

6.  Accuracy of family history of cancer as reported by men with prostate cancer.

Authors:  Terri M King; L Tong; Rebecca J Pack; Cheri Spencer; Christopher I Amos
Journal:  Urology       Date:  2002-04       Impact factor: 2.649

7.  Familial and second esophageal cancers: a nation-wide epidemiologic study from Sweden.

Authors:  Kari Hemminki; Yongwen Jiang
Journal:  Int J Cancer       Date:  2002-03-01       Impact factor: 7.396

8.  Family history of colorectal cancer in a Sweden county.

Authors:  Louise Olsson; Annika Lindblom
Journal:  Fam Cancer       Date:  2003       Impact factor: 2.375

9.  Familial risk of cancer: data for clinical counseling and cancer genetics.

Authors:  Kari Hemminki; Xinjun Li; Kamila Czene
Journal:  Int J Cancer       Date:  2004-01-01       Impact factor: 7.396

10.  Molecular analysis of hereditary nonpolyposis colorectal cancer in the United States: high mutation detection rate among clinically selected families and characterization of an American founder genomic deletion of the MSH2 gene.

Authors:  Anja Wagner; Alicia Barrows; Juul Th Wijnen; Heleen van der Klift; Patrick F Franken; Paul Verkuijlen; Hidewaki Nakagawa; Marjan Geugien; Shantie Jaghmohan-Changur; Cor Breukel; Hanne Meijers-Heijboer; Hans Morreau; Marjo van Puijenbroek; John Burn; Stephany Coronel; Yulia Kinarski; Ross Okimoto; Patrice Watson; Jane F Lynch; Albert de la Chapelle; Henry T Lynch; Riccardo Fodde
Journal:  Am J Hum Genet       Date:  2003-03-25       Impact factor: 11.025

View more
  15 in total

1.  Familial risks of acute myeloid leukemia, myelodysplastic syndromes, and myeloproliferative neoplasms.

Authors:  Amit Sud; Subhayan Chattopadhyay; Hauke Thomsen; Kristina Sundquist; Jan Sundquist; Richard S Houlston; Kari Hemminki
Journal:  Blood       Date:  2018-07-10       Impact factor: 22.113

2.  Analysis of 153 115 patients with hematological malignancies refines the spectrum of familial risk.

Authors:  Amit Sud; Subhayan Chattopadhyay; Hauke Thomsen; Kristina Sundquist; Jan Sundquist; Richard S Houlston; Kari Hemminki
Journal:  Blood       Date:  2019-08-08       Impact factor: 22.113

3.  On using a cancer center cancer registry to identify newly affected women eligible for hereditary breast cancer syndrome testing: practical considerations.

Authors:  Tiffani A DeMarco; Christopher A Loffredo; Marilyn L Sampilo; Kenneth P Tercyak
Journal:  J Genet Couns       Date:  2006-04       Impact factor: 2.537

4.  Evaluation of BRCA1 and BRCA2 mutation prevalence, risk prediction models and a multistep testing approach in French-Canadian families with high risk of breast and ovarian cancer.

Authors:  Jacques Simard; Martine Dumont; Anne-Marie Moisan; Valérie Gaborieau; Hélène Malouin; Francine Durocher; Jocelyne Chiquette; Marie Plante; Denise Avard; Paul Bessette; Claire Brousseau; Michel Dorval; Béatrice Godard; Louis Houde; Yann Joly; Marie-Andrée Lajoie; Gilles Leblanc; Jean Lépine; Bernard Lespérance; Hélène Vézina; Jillian Parboosingh; Roxane Pichette; Louise Provencher; Josée Rhéaume; Daniel Sinnett; Carolle Samson; Jean-Claude Simard; Martine Tranchant; Patricia Voyer; Douglas Easton; Sean V Tavtigian; Bartha-Maria Knoppers; Rachel Laframboise; Peter Bridge; David Goldgar
Journal:  J Med Genet       Date:  2006-08-11       Impact factor: 6.318

5.  The Y deletion gr/gr and susceptibility to testicular germ cell tumor.

Authors:  Katherine L Nathanson; Peter A Kanetsky; Rachel Hawes; David J Vaughn; Richard Letrero; Kathy Tucker; Michael Friedlander; Kelly-Anne Phillips; David Hogg; Michael A S Jewett; Radka Lohynska; Gedske Daugaard; Stéphane Richard; Agnés Chompret; Catherine Bonaïti-Pellié; Axel Heidenreich; Edith Olah; Lajos Geczi; Istvan Bodrogi; Wilma J Ormiston; Peter A Daly; J Wolter Oosterhuis; Ad J M Gillis; Leendert H J Looijenga; Parry Guilford; Sophie D Fosså; Ketil Heimdal; Sergei A Tjulandin; Ludmila Liubchenko; Hans Stoll; Walter Weber; Matthew Rudd; Robert Huddart; Gillian P Crockford; David Forman; D Timothy Oliver; Lawrence Einhorn; Barbara L Weber; Joan Kramer; Mary McMaster; Mark H Greene; Malcolm Pike; Victoria Cortessis; Chu Chen; Stephen M Schwartz; D Timothy Bishop; Douglas F Easton; Michael R Stratton; Elizabeth A Rapley
Journal:  Am J Hum Genet       Date:  2005-10-24       Impact factor: 11.025

6.  Familial risks in nervous system tumours: joint Nordic study.

Authors:  K Hemminki; S Tretli; J H Olsen; L Tryggvadottir; E Pukkala; J Sundquist; C Granström
Journal:  Br J Cancer       Date:  2010-05-25       Impact factor: 7.640

7.  The Swedish family-cancer database: update, application to colorectal cancer and clinical relevance.

Authors:  Kari Hemminki; Charlotta Granström; Bowang Chen
Journal:  Hered Cancer Clin Pract       Date:  2005-01-15       Impact factor: 2.857

8.  The updated Swedish family-cancer database used to assess familial risks of prostate cancer during rapidly increasing incidence.

Authors:  Kari Hemminki; Charlotta Granström; Jan Sundquist; Justo Lorenzo Bermejo
Journal:  Hered Cancer Clin Pract       Date:  2006-12-15       Impact factor: 2.857

Review 9.  Partnering in oncogenetic research--the INHERIT BRCAs experience: opportunities and challenges.

Authors:  Denise Avard; Peter Bridge; Lucie M Bucci; Jocelyne Chiquette; Michel Dorval; Francine Durocher; Doug Easton; Béatrice Godard; David Goldgar; Bartha Maria Knoppers; Rachel Laframboise; Bernard Lespérance; Marie Plante; Sean V Tavtigian; Hélène Vézina; Brenda Wilson; Jacques Simard
Journal:  Fam Cancer       Date:  2006       Impact factor: 2.375

10.  Familial multiple myeloma: report on two families and discussion of screening options.

Authors:  Erica H Gerkes; Mirjam M de Jong; Rolf H Sijmons; Edo Vellenga
Journal:  Hered Cancer Clin Pract       Date:  2007-06-15       Impact factor: 2.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.